These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9550326)

  • 41. A supertypic HLA class II determinant shared by DR1 and DRw9, and crossreactive with DR2, defined by human monoclonal antibody.
    Kosinski S; Yang SY; Pistillo MP; Hämmerling U
    Hum Immunol; 1988 Mar; 21(3):221-31. PubMed ID: 2453492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
    Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
    Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes.
    Meiring HD; Kuipers B; van Gaans-van den Brink JA; Poelen MC; Timmermans H; Baart G; Brugghe H; van Schie J; Boog CJ; de Jong AP; van Els CA
    J Immunol; 2005 May; 174(9):5636-43. PubMed ID: 15843563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.
    Peters HL; Tripathi SC; Kerros C; Katayama H; Garber HR; St John LS; Federico L; Meraz IM; Roth JA; Sepesi B; Majidi M; Ruisaard K; Clise-Dwyer K; Roszik J; Gibbons DL; Heymach JV; Swisher SG; Bernatchez C; Alatrash G; Hanash S; Molldrem JJ
    Cancer Immunol Res; 2017 Apr; 5(4):319-329. PubMed ID: 28254787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allo-cross-reactivity of a human neuraminidase-specific T cell clone dependent on presentation of an endogenous B cell-specific antigen.
    Kuijpers KC; Treep-Van Leeuwen P; Miedema F; Lucas CJ
    Eur J Immunol; 1991 Jun; 21(6):1453-60. PubMed ID: 1710566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.
    Ballas M; Eiermann TH; Wölpl A; Goldmann SF
    Tissue Antigens; 1990 Nov; 36(5):187-93. PubMed ID: 1710076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.
    Whitelegg AM; Oosten LE; Jordan S; Kester M; van Halteren AG; Madrigal JA; Goulmy E; Barber LD
    J Immunol; 2005 Aug; 175(3):1706-14. PubMed ID: 16034111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401.
    Gaseitsiwe S; Valentini D; Mahdavifar S; Reilly M; Ehrnst A; Maeurer M
    Clin Vaccine Immunol; 2010 Jan; 17(1):168-75. PubMed ID: 19864486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of antigen-specific T cell activation by staphylococcal enterotoxins.
    Dowd JE; Jenkins RN; Karp DR
    J Immunol; 1995 Feb; 154(3):1024-31. PubMed ID: 7822779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
    Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II
    Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
    Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
    Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing.
    Vergelli M; Pinet V; Vogt AB; Kalbus M; Malnati M; Riccio P; Long EO; Martin R
    Eur J Immunol; 1997 Apr; 27(4):941-51. PubMed ID: 9130648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation and characterization of a human monoclonal IgG antibody specific for HLA-B12.
    Siemoneit K; Wölpl A; Wegener S; Ernst M; Sonneborn HH; Goldmann SF
    Tissue Antigens; 1994 Jul; 44(1):25-33. PubMed ID: 7526486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates.
    Geluk A; Elferink DG; Slierendregt BL; van Meijgaarden KE; de Vries RR; Ottenhoff TH; Bontrop RE
    J Exp Med; 1993 Apr; 177(4):979-87. PubMed ID: 8459225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
    de Koster HS; van Rood JJ; Termijtelen A
    Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abundant empty class II MHC molecules on the surface of immature dendritic cells.
    Santambrogio L; Sato AK; Fischer FR; Dorf ME; Stern LJ
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15050-5. PubMed ID: 10611336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes.
    Weidanz JA; Piazza P; Hickman-Miller H; Woodburn D; Nguyen T; Wahl A; Neethling F; Chiriva-Internati M; Rinaldo CR; Hildebrand WH
    J Immunol Methods; 2007 Jan; 318(1-2):47-58. PubMed ID: 17134715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.